Clinical Trial Update: Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial evaluated rasagiline in Parkinson's disease patients on levodopa with motor fluctuations; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED